MedPath

Effect of Parent-Focused Group Schema Therapy for Adolescents with Anorexia Nervosa:

Not Applicable
Recruiting
Conditions
Anorexia Nervosa.
Anorexia nervosa
F50.0
Registration Number
IRCT20220714055467N1
Lead Sponsor
Shiraz University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
18
Inclusion Criteria

Parents of adolescents between the ages of 12 and 18 Having at least a caregiver in the home willing to participate in treatment Adolescents must meet DSM-5 criteria for Anorexia Nervosa based on the clinical interview Having body mass index (BMI) between 14 and 18 Being sufficiently medically stable for outpatient treatment Parents must read and speak Persian to at least a sixth-grade level Adolescents on psychotropic medication must be on a stable dose for a period of at least 8 weeks

Exclusion Criteria

Adolescents with severe substance abuse, acute psychosis, or at acute risk for suicide Adolescents or caregivers with intellectual disability Experience of participating in Schema Therapy sessions with a trained clinician over the past 12 months before the study begins Report of a current or history of recent or past physical or sexual abuse by a family member

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The score of the Eating Disorder Examination questionnaire (EDEQ). Timepoint: Measuring the eating disorder in Baseline, Mid-treatment, post-treatment and 3- month follow-up. Method of measurement: Eating Disorder Examination questionnaire (EDEQ).;The score of Parent-Child Interaction Questionnaire-Revised (PACHIQ-R). Timepoint: Measuring the parent-child interaction in Baseline, Mid-treatment, post-treatment and 3- month follow-up. Method of measurement: Parent-Child Interaction Questionnaire-Revised (PACHIQ-R).
Secondary Outcome Measures
NameTimeMethod
The score of Difficulties in Emotion Regulation Scale (DERS-16). Timepoint: Measuring the parents' emotion regulation in Baseline, Mid-treatment, Post-treatment and 3-months follow-up. Method of measurement: The Difficulties in Emotion Regulation Scale (DERS-16).;The score of Family Quality of Life Scale (FQOL). Timepoint: Measuring the family's quality of life in Baseline, Mid-treatment, Post-treatment and 3-months follow-up. Method of measurement: Family Quality of Life Scale (FQOL).;The score of Visual Analogue Scale (VAS). Timepoint: The VAS scales will be collected twice per week during baseline period, once a week after each group session, twice per week during the follow-up and once during the follow-up measure. Method of measurement: Visual Analogue Scale (VAS).
© Copyright 2025. All Rights Reserved by MedPath